Muscle pain is not listed among the most common tirzepatide reactions, but some patients report body aches, soreness, or weakness during treatment
GLP-1 medications cause rapid weight loss by significantly suppressing appetite
The major central endocannabinoid directly acts at GABA A receptors
It works through one core pathway tied to appetite signalling, gastric emptying, insulin response, and metabolic regulation
Titration Phase Week 5-8: 0.5 mg once weekly Purpose: Gradually increasing the dose helps improve the bodys tolerance to the medication and enhances its effectiveness in blood sugar control and weight loss
Any product that contains a GLP-1 analogue or other peptide drug analogue, or that makes medicinal claims, is classified as a medicine under MHRA borderline product rules not a food supplement